France · Health Care · EUR (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in EUR (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for AFFLUENT MEDICAL? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -47.7% | -23.41% | -32.99% | -58.07% | -117.7% | -197.1% |
|---|---|---|---|---|---|---|
| ROA | -25.08% | -10.03% | -9.93% | -10.49% | -10.49% | -10.54% |
| Gross Margin | 20.79% | 18.92% | 16.54% | 15% | 15% | 15% |
| Net Margin | -357.92% | -133.04% | -132.42% | -134.89% | -138.09% | -139.52% |
| Total Assets | €60,858.00K | €65,628.32K | €70,780.27K | €76,344.37K | €82,353.60K | €88,843.56K |
| Net Income | -€14,739.00K | -€6,343.45K | -€6,775.61K | -€7,718.68K | -€8,327.19K | -€9,025.97K |